BRPI0919168A2 - pestivírus mutante, e, vacina. - Google Patents

pestivírus mutante, e, vacina.

Info

Publication number
BRPI0919168A2
BRPI0919168A2 BRPI0919168A BRPI0919168A BRPI0919168A2 BR PI0919168 A2 BRPI0919168 A2 BR PI0919168A2 BR PI0919168 A BRPI0919168 A BR PI0919168A BR PI0919168 A BRPI0919168 A BR PI0919168A BR PI0919168 A2 BRPI0919168 A2 BR PI0919168A2
Authority
BR
Brazil
Prior art keywords
vaccine
mutant pestivirus
pestivirus
mutant
Prior art date
Application number
BRPI0919168A
Other languages
English (en)
Inventor
Hans Tillmann Ruemenapf
Heinz-Jurgen Thiel
Manuela Heimann
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BRPI0919168A2 publication Critical patent/BRPI0919168A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
BRPI0919168A 2008-09-17 2009-09-16 pestivírus mutante, e, vacina. BRPI0919168A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08164496 2008-09-17
PCT/EP2009/061989 WO2010031783A1 (en) 2008-09-17 2009-09-16 Mutant pestivirus with mutations in core gene and ns3 region

Publications (1)

Publication Number Publication Date
BRPI0919168A2 true BRPI0919168A2 (pt) 2015-12-08

Family

ID=40336636

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919168A BRPI0919168A2 (pt) 2008-09-17 2009-09-16 pestivírus mutante, e, vacina.

Country Status (12)

Country Link
US (1) US20110229520A1 (pt)
EP (1) EP2324112B1 (pt)
JP (1) JP2012502641A (pt)
CN (1) CN102159705B (pt)
AR (1) AR073594A1 (pt)
AU (1) AU2009294654A1 (pt)
BR (1) BRPI0919168A2 (pt)
ES (1) ES2387637T3 (pt)
MX (1) MX2011002870A (pt)
RU (1) RU2483106C2 (pt)
WO (1) WO2010031783A1 (pt)
ZA (1) ZA201101666B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102517260A (zh) * 2011-12-29 2012-06-27 中国人民解放军军事医学科学院野战输血研究所 携带牛病毒性腹泻病毒非结构蛋白ns3优势区的融合蛋白及其重组表达方法与应用
NZ631110A (en) * 2012-08-29 2015-11-27 Intervet Int Bv Marker vaccine
BR112016014010B1 (pt) * 2013-12-19 2022-08-30 Intervet International B.V. Método para detectar anticorpos contra vírus da febre suína clássica tipo selvagem (csfv) em uma amostra de teste e kit de teste de diagnóstico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531776A1 (fr) * 1982-08-13 1984-02-17 Commissariat Energie Atomique Procede et dispositif de determination sans contact de la rugosite d'une surface
US7049428B1 (en) * 1998-03-04 2006-05-23 Washington University HCV variants
EP0982402A1 (en) * 1998-08-14 2000-03-01 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Pestivirus vaccination
US6326137B1 (en) * 1999-06-25 2001-12-04 Schering Corporation Hepatitis C virus protease-dependent chimeric pestivirus
US7332170B1 (en) * 2005-12-23 2008-02-19 The United States Of America, As Represented By The Secretary Of Agriculture Classical swine fever virus virulence determinant and a novel classical swine fever vaccine

Also Published As

Publication number Publication date
EP2324112A1 (en) 2011-05-25
AR073594A1 (es) 2010-11-17
EP2324112B1 (en) 2012-05-30
CN102159705A (zh) 2011-08-17
ES2387637T3 (es) 2012-09-27
US20110229520A1 (en) 2011-09-22
AU2009294654A1 (en) 2010-03-25
RU2483106C2 (ru) 2013-05-27
ZA201101666B (en) 2011-11-30
JP2012502641A (ja) 2012-02-02
WO2010031783A1 (en) 2010-03-25
MX2011002870A (es) 2011-04-26
RU2011114984A (ru) 2012-10-27
CN102159705B (zh) 2013-02-13

Similar Documents

Publication Publication Date Title
BRPI0915433A2 (pt) método, e, dispositivo.
BRPI0909770A2 (pt) Vacina, e, kit
BRPI0911351A2 (pt) estrutura de sent, e , prótese de válvula.
BRPI0813235A2 (pt) Combinação anti-helmíntica.
FR2909857B1 (fr) Endovalve.
BRPI0815773A2 (pt) composto, e, medicamento.
BRPI0923409A2 (pt) cabeça de escova de dentes, e, escova de dentes.
ATE513831T1 (de) Pyridinä3,4-büpyrazinone
BRPI0913112A2 (pt) fluxímetro, e, método.
BRPI0920953A2 (pt) dispositivo de manutenção, e uso do mesmo.
BRPI0911252A2 (pt) método, extrato, e, composição.
BRPI0914584A2 (pt) Método, e, composição herbicida.
JP2012513655A5 (pt)
BRPI0919168A2 (pt) pestivírus mutante, e, vacina.
IT1396642B1 (it) Statore.
FI7604U1 (fi) Tuntoelin
BRPI0813187A2 (pt) 13-hidroperóxido liases modificadas e respectivos usos.
FR2903669B3 (fr) 02isse demontable.
BRPI1007505A2 (pt) derivado de tetraidronaftaleno-2-ol, e, uso do mesmo.
NL1034526A1 (nl) Emoticoninrichting.
ITPR20080004A1 (it) Seggiola.
ITCE20060002A1 (it) Patok.
ITMC20070246A1 (it) Sgabello monogamba.
NL2001298A1 (nl) Handkruk.
ITNA20070005A1 (it) Fosfotriesterasi termofile e termostabili ottenibili per via ricombinante.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.